Approvals (Drugs@FDA)

EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE

APOTEX · EMTRICITABINE, TENOFOVIR ALAFENAMIDE FUMARATE

ANDA214053Generic (ANDA)Discontinued
Open FDA's page for this record
Application number
ANDA214053
Sponsor name
APOTEX
Submissions
  1. Submission type
    ORIG
    Submission number
    1
    Submission status
    AP
    Submission status date
    20240517
    Review priority
    STANDARD
    Submission class code
    UNKNOWN
    Application docs
    1. ID
      78836
      Url
      https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/214053Orig1s000ltr.pdf
      Date
      20240620
      Type
      Letter
Products
  1. Product number
    002
    Reference drug
    No
    Brand name
    EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE
    Reference standard
    No
    Dosage form
    TABLET
    Route
    ORAL
    Marketing status
    Discontinued
    Te code
    AB
    Active ingredients
    1. Name
      EMTRICITABINE
      Strength
      200MG
    2. Name
      TENOFOVIR ALAFENAMIDE FUMARATE
      Strength
      EQ 25MG BASE
  2. Product number
    001
    Reference drug
    No
    Brand name
    EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE
    Reference standard
    No
    Dosage form
    TABLET
    Route
    ORAL
    Marketing status
    Discontinued
    Te code
    AB
    Active ingredients
    1. Name
      EMTRICITABINE
      Strength
      120MG
    2. Name
      TENOFOVIR ALAFENAMIDE FUMARATE
      Strength
      EQ 15MG BASE
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Join as a DoctorSell on MedGrid

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.